Fund

Innovative Health Initiative

The Innovative Health Initiative (IHI) is a public-private partnership (PPP) between the European Union and the European life science industries. On this page we have compiled key program information.

Innovative Health Initiative 2024 Call Information

IHI hold two types of calls, Single stage and Two stage calls. Below are some themes that may be included in the call for proposals. Additional information regarding the calls can be found here.
Update: IHI call 7 is now open for proposals.

  • Call launch: 16 January 2024
  • Full proposal submission deadline: 22 May 2024

IHI Call 7 Information

The projects funded under this topic should develop or improve innovative medical technology solutions. Through collaborative design approaches incorporating the feedback of end-users, the solutions should be easy-to-use, clearly identify and tackle any ethical concerns, and aim to be ready for integration into real-world hospital environments. Applicants should also consider the ethical and societal implications of the proposed solutions, involving the perspectives and preferences of patients and their families as the ultimate beneficiaries.

  • Call launch: 16 January 2024
  • Full proposal submission deadline: 22 May 2024

IHI call 7 is focusing on the following activities:

  • Develop and implement solutions to empower the healthcare workforce, by supporting and assisting them without introducing additional burdens.
    • Propose solutions (up to a prototype level) that may relate either to the automation of existing workflows, or the adoption and the integration of new capacities and/or the development of trustworthy and autonomous technologies or technology (AI)1 experiences.
    • These solutions should be data-driven, aiming to improve workflows and assist clinical procedures and/or hospital processes, supporting in planning and creating a more efficient and balanced supply and demand between patient load and staff competencies and healthcare resource consumption.
    • Applicants should take into consideration standardised approaches to data acquisition to allow proper development/training of the technologies.
  • Propose and implement a strategy for better integration of existing and/or emerging technologies in different hospital workflows. This may include an analysis of the most critical processes running in hospitals, technological gaps within the hospital environment, ways to optimise workflow(s), and a roadmap of how the proposed technologies can grow, adapt, and innovate to meet the future needs of a healthcare system and its staff.
  • Demonstrate potential for deployment through use cases that address wide user groups involving all relevant medical staff categories (nurses, medical staff, specialists, managers, etc.).
  • Establish effective training approaches for complex technologies to minimise user burden and operator error, and/or to improve patient outcomes.
  • Convincingly demonstrate the scalability and transferability of the approaches across different healthcare professions and different levels of care.
  • Demonstrate the feasibility and desirability of the proposed approach(es) or technologies from an economic perspective, analysing the potential impact on patient and staff costs in healthcare institutions, on payers and insurers, and on the healthcare system. Applicants should consider relevant strategies to drive end-user and organisation-wide adoption.
  • Where relevant, the proposed solutions should aim at developing and applying relevant standards (e.g. Fast Health Interoperability Resources (FHIR), Health Level Seven International (HL7), Integrating the Healthcare Enterprise (IHE), Logical Observation Identifiers Names and Codes (LOINC), Systemized Nomenclature of Medicine – Clinical Terms (SNOMED CT), Business Process Model and Notation (BPMN)) and ensuring the potential for regulatory approval, taking into consideration the different national regulatory requirements to ensure future implementation in the target markets.
  • If relevant, applicants should take into account other dimensions with regulatory implications (for example the prevention and management of shortages, implementation of risk minimisation measures following regulatory decisions, the incorporation of clinical trial design requirements, and collecting real world data (RWD) for regulatory purposes).
  • Where applicable, applicants should ensure the proposed solutions take into consideration supporting the secondary use of data generated for research, including by regulators.

 

Visit the Innovative Health Initiative website for more information.

 

Innovative Health Initiative’s objectives

IHI’s general objectives are to: Turn health research and innovation into real benefits for patients and society; deliver safe, effective health innovations that cover the entire spectrum of care – from prevention to diagnosis and treatment – particularly in areas where there is an unmet public health need; and make Europe’s health industries globally competitive.

 


About Catalyze

At Catalyze we commit ourselves to accelerate innovations that have a positive impact on the world. We are the driving force for innovations across the fields of Life Sciences and Sustainability. Our offering of strategic consulting services, funding consulting, project management and more, deliver impactful expertise for all development stages. With a proven track record and the highest quality and success rate in the industry, we aim to be the consulting partner of choice to drive the success of meaningful innovation projects.

Learn more 


 

Newsletter

A must-have if you’re interested in getting your business to the next level